Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Reformulated sampatrilat shows improved bioavailability in animal model

Dec. 29, 2000

Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity

Dec. 27, 2000

Sumitomo discloses thiourea derivatives with ECE-inhibitory activity

Dec. 27, 2000

Myogen and BASF to codevelop BSF-208075

Dec. 27, 2000

Dual inhibitors of ACE/NEP in development at Toa Eiyo

Dec. 22, 2000

Ranolazine enters phase II for CHF

Dec. 22, 2000

NDA for UT-15 will not require FDA advisory committee review

Dec. 20, 2000

Research on Alteon's ALT-711 fueled by ADA grant; phase IIa trial on target

Dec. 19, 2000

Inhibitors of Lp-PLA2 and their use in atherosclerosis described by SB in recent patent

Dec. 18, 2000

Novel Aventis compounds for cardiovascular disorders interact with angiotensin receptors

Dec. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...